Table 4.

Adverse events as percentage of subjects per group during the three treatment blocks

	Iscucin® Populi			Viscum Mali e planta tota			Placebo
	(n = 30)			(n = 21)			(n = 20)
Description of AE	0.0125%	0.25%	5%	1:1000	1:100	1:50
	strength	strength	strength	D3	D2	2%
	F	G	H
	Week	Week	Week	Week	Week	Week	Week	Week	Week
	1-4	5-8	9-12	1-4	5-8	9-12	1-4	5-8	9-12
Abdominal pain (%)	0	3	3	0	0	0	0	0	0
Common cold (%)	27	17	17	38	14	10	15	15	25
Diarrhea (%)	0	3	0	0	0	0	0	0	0
Dizziness (%)	0	3	0	0	0	0	5	0	0
Fatigue (%)	0	0	3	0	0	0	0	0	0
Fever (%)	0	3	0	0	0	0	0	0	0
Headache (%)	13	0	3	14	5	10	5	10	10
Nausea (%)	0	3	3	0	0	0	0	0	0
Swollen lymph nodes (%)	0	3	7	0	0	0	0	0	0
Vomiting (%)	3	3	0	0	0	0	0	0	0
Weakness (%)	0	0	0	5	0	0	5	0	0